Information Provided By:
Fly News Breaks for April 17, 2019
WBA
Apr 17, 2019 | 16:37 EDT
Guggenheim analyst Glen Santangelo assumed coverage of Walgreens Boots Alliance and downgraded the shares to Neutral from the firm's Buy rating under analyst John Heinbockel. He lowered his price target for the stock to $59 from $75. The analyst is concerned about the continuing structural pressures facing the retail pharmacy industry. Further, the evolution of Walgreens' competitive landscape "will continue to make things difficult for the company," Santangelo tells investors in a research note.
News For WBA From the Last 2 Days
WBA
Mar 27, 2024 | 13:20 EDT
Notable companies reporting before tomorrow's open, with earnings consensus, include Walgreens Boots Alliance (WBA), consensus 82c.
WBA
Mar 26, 2024 | 06:33 EDT
Morgan Stanley lowered the firm's price target on Walgreens Boots Alliance to $21 from $22 and keeps an Underweight rating on the shares. Ahead of the company's Q2 report, the firm is tempering its FY24 EPS estimate to $3.24 from $3.35 to reflect a variable consumer backdrop. While "hopeful" about Walgreens' turnaround prospects, cost cutting, and pruning of assets, the firm awaits detail on the new CEO's vision and tells investors it is "still likely too early."